Original article
Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression
Lucia Vráblováa, Hana Klamováb, Ivana Skoumalováa, Jana Navrátilováa, Romana Janskáa, Jan Grohmanna, Milena Holzerováa, Edgar Fabera,
Autor para correspondência
edgar.faber@fnol.cz
Corresponding author at: Department of Hemato-Oncology, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic.
Corresponding author at: Department of Hemato-Oncology, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic.
Lido
1205
Vezesque se leu este artigo
287
Total PDF
918
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 48 | 6 | 54 |
| 2025 5 | 94 | 17 | 111 |
| 2025 4 | 93 | 22 | 115 |
| 2025 3 | 77 | 18 | 95 |
| 2025 2 | 62 | 28 | 90 |
| 2025 1 | 61 | 16 | 77 |
| 2024 12 | 74 | 22 | 96 |
| 2024 11 | 96 | 30 | 126 |
| 2024 10 | 61 | 23 | 84 |
| 2024 9 | 76 | 34 | 110 |
| 2024 8 | 114 | 35 | 149 |
| 2024 7 | 62 | 36 | 98 |
